Related Experiment Videos

Systematic review: managing anaemia in Crohn's disease

S Kulnigg1, C Gasche

  • 1Department of Medicine, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.

Insights

Anaemia is a common complication of Crohn's disease, often caused by iron deficiency. Intravenous iron is a safe and effective treatment for anaemia in Crohn's disease patients.

Area of Science:

  • Gastroenterology
  • Hematology
  • Internal Medicine

Background:

  • Anaemia is a significant complication of Crohn's disease, potentially leading to hospitalization and mortality.
  • The prevalence of anaemia in Crohn's disease varies widely, with higher rates reported in older studies and inpatient populations.

Purpose of the Study:

  • To systematically review and compare existing literature on anaemia in Crohn's disease.
  • To synthesize information on prevalence, causes, diagnostic methods, and therapeutic approaches.

Main Methods:

  • A systematic literature search was conducted using keywords: anaemia, Crohn*, and IBD.
  • 144 English-language articles were identified and categorized by topic.
  • Data were analyzed to summarize findings on prevalence, aetiology, diagnostics, and therapy.

Main Results:

  • Iron deficiency is the most frequent cause of anaemia in Crohn's disease.
  • While oral iron supplementation may be effective short-term, intolerance is common (up to 21%) and it may exacerbate intestinal inflammation in animal models.
  • Intravenous iron sucrose has demonstrated safety and efficacy in over 250 Crohn's disease patients.

Conclusions:

  • Effective management of Crohn's disease activity is crucial for reducing anaemia incidence.
  • Further research is necessary to fully establish the safety and effectiveness of iron supplementation strategies.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...